Abbott's Appeal Tentatively OK'd In Norvir Suit

By Erin Marie Daly

Law360, New York (August 19, 2008, 12:00 AM ET) -- A district judge in California has tentatively given the green light for Abbott Laboratories to seek interlocutory appeal of several contentious antitrust issues that have arisen in one of several suits the company is facing for allegedly jacking up the price of its HIV medication Norvir.

During a hearing Tuesday in federal court in Oakland, Calif., Judge Claudia Wilken indicated she was leaning in favor of granting leave for the pharmaceutical giant to apply for an interlocutory appeal to the U.S. Court of Appeals for the...
To view the full article, take a free trial now.

Already a subscriber? Click here to login

You must correct or enter the following before you can submit this form:

All fields required

  5. Required

Only Law360 gives you:

Non-stop coverage of high-stakes litigation across 30 practices

Real-time tracking and reports on 10,000+ companies, firms and industries

Over 80,000 attorney profiles with neutral data collected from active lawsuits

Research tools to find cases, court documents, attorneys and companies

Customized feeds and alerts that can easily be shared with colleagues

In-depth expert analysis from high-profile attorneys at top firms

Access to our vault with over 75,000 original articles